Health Canada has launched a consultation on proposed amendments to the Food and Drug Regulations and Medical Devices Regulations (the Regulatory Amendments). Consultation on the Regulatory Amendments, which have been published in the Canada Gazette, Part 1, is
Pharmaceuticals and life sciences
Two PM(NOC) Actions Dismissed After Common Trial on Validity of Treatment Regimen Patent
The Federal Court has dismissed two infringement actions brought against defendants under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations (Regulations), following a common trial on the validity of Canadian Patent No. 2,562,277 (277 Patent…
Top Headlines of 2018
Last year ushered in a number of changes to the Canadian pharmaceutical and life sciences sector. 2018 also served as a year to explore the impacts of major intellectual property decisions and regulatory changes from 2017 including the impact of…
Pharma in brief – TMOB dismisses section 45 proceedings for the trade-mark REMODULIN
Case: Blake, Cassels & Graydon LLP v United Therapeutics Corporation, 2017 TMOB 9
Trade-Mark: REMODULIN
Nature of case: Summary expungement proceedingpursuant to section 45 of Trade-marks Act
Successful party: United Therapeutics Corporation
Date of decision: January 26, 2017
Summary
…